{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:57:43Z","timestamp":1790207863413,"version":"4.1.0"},"reference-count":41,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Photodynamic therapy (PDT) is safe and effective in the treatment of patients with actinic keratosis (AK). The aim of the study was to assess the efficacy, tolerability and cosmetic outcome of topical PDT in the treatment of AKs with three forms of photosensitizers: 5-Aminolevulinic acid hydrochloride (ALA-HCl), 5-Aminolevulinate methyl ester hydrochloride (MAL-HCl) and 5-Aminolevulinate phosphate (ALA-P). The formulations were applied onto selected scalp\/face areas. Fluorescence was assessed with a FotoFinder Dermoscope 800 attachment. Skin areas were irradiated with Red Beam Pro+, Model APRO (MedLight GmbH, Herford, Germany). Applied treatments were assessed during the PDT as well as 7 days and 12 weeks after its completion. Ninety-four percent of patients rated obtained cosmetic effect excellent. The efficacy of applied PSs did not differ significantly. However, pain intensity during the PDT procedure was significantly lower in the area treated with ALA-P (5.8 on average) in comparison to the areas treated with ALA-HCl or MAL-HCl (7.0 on average on 0\u201310 scale). Obtained results show that ALA-P may undergo more selective accumulation than ALA-HCl and MAL-HCl. Our promising results suggest that PDT with the use of ALA-P in AK treatment may be an advantageous alternative to the already used ALA-HCl and MAL-HCl.<\/jats:p>","DOI":"10.3390\/pharmaceutics14020346","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T22:16:18Z","timestamp":1643753778000},"page":"346","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Topical Photodynamic Therapy with Different Forms of 5-Aminolevulinic Acid in the Treatment of Actinic Keratosis"],"prefix":"10.3390","volume":"14","author":[{"given":"Joanna","family":"Bartosi\u0144ska","sequence":"first","affiliation":[{"name":"Department of Cosmetology and Aesthetic Medicine, Medical University of Lublin, Chod\u017aki 1 St., 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3205-5407","authenticated-orcid":false,"given":"Paulina","family":"Szczepanik-Ku\u0142ak","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, Staszica 11 St., 20-081 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3517-6711","authenticated-orcid":false,"given":"Dorota","family":"Raczkiewicz","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, School of Public Health, Center of Postgraduate Medical Education, Kleczewska 61\/63 St., 01-826 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Niewiedzio\u0142","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, Staszica 11 St., 20-081 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Gerkowicz","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, Staszica 11 St., 20-081 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7458-5054","authenticated-orcid":false,"given":"Dorota","family":"Kowalczuk","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Faculty of Pharmacy, Medical University of Lublin, Jaczewskiego 4 St. 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miros\u0142aw","family":"Kwa\u015bny","sequence":"additional","affiliation":[{"name":"Institute of Optoelectronics, The Military University of Technology, Kaliskiego 2 St., 01-476 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3176-9870","authenticated-orcid":false,"given":"Dorota","family":"Krasowska","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, Staszica 11 St., 20-081 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/jamainternmed.2016.5008","article-title":"Skin cancer-the importance of prevention","volume":"176","author":"Linos","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.2217\/fon.15.180","article-title":"Burden of basal cell carcinoma in USA","volume":"11","author":"Wu","year":"2015","journal-title":"Future Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e2020066","DOI":"10.5826\/dpc.1003a66","article-title":"Squamous cell carcinoma: An update on diagnosis and treatment","volume":"10","author":"Combalia","year":"2020","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/ijd.14767","article-title":"Current therapies for actinic keratosis","volume":"59","author":"Dianzani","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Department of veteran affairs topical tretinoin chemoprevention trial group. Actinic keratoses: Natural history and risk of malignant transformation in the veterans affairs topical tretinoin chemoprevention trial","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jdv.12848","article-title":"Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin","volume":"29","author":"Carrato","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jdv.12827","article-title":"From a new vision of actinic keratosis to imiquimod 3.75%, the new treatment standard","volume":"29","author":"Stockfleth","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40257-018-0348-7","article-title":"Field cancerization therapies for management of actinic keratosis: A narrative review","volume":"19","author":"Jetter","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_9","first-page":"138","article-title":"Photodynamic therapy in dermatology","volume":"4","year":"2018","journal-title":"Forum. Derm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s13555-020-00425-4","article-title":"Management pearls on the treatment of actinic keratoses and field cancerization","volume":"10","author":"Gilaberte","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1590\/S0365-05962010000500007","article-title":"Photodynamic therapy with delta-aminolevulinic acid and light-emitting diodes in actinic keratosis","volume":"85","author":"Ritter","year":"2010","journal-title":"An. Bras. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.clon.2019.08.011","article-title":"Evolving role of systemic therapies in non-melanoma skin cancer","volume":"31","author":"Conforti","year":"2019","journal-title":"Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"111544","DOI":"10.1016\/j.jphotobiol.2019.111544","article-title":"Photodynamic therapy for skin cancer: How to enhance drug penetration?","volume":"197","author":"Champeau","year":"2019","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pdpdt.2017.07.010","article-title":"Pain during topical photodynamic therapy\u2014Comparing methyl aminolevulinate (Metvix \u00ae) to aminolaevulinic acid (Ameluz \u00ae); an intra-individual clinical study","volume":"20","author":"Yazdanyar","year":"2017","journal-title":"Photodiagnosis. Photodyn. Ther."},{"key":"ref_15","unstructured":"National Center for Biotechnology Information (2021, August 06). PubChem Compound Summary for CID 24737828, Aminolevulinic Acid Phosphate, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Aminolevulinic-acid-phosphate."},{"key":"ref_16","first-page":"8294805","article-title":"The safety and tolerability of 5-aminolevulinic acid phosphate with sodium ferrous citrate in patients with type 2 diabetes mellitus in Bahrain","volume":"2016","author":"Aldosari","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"16004","DOI":"10.1038\/s41598-020-72763-4","article-title":"Reduction of fatigue and anger-hostility by the oral administration of 5-aminolevulinic acid phosphate: A randomized, double-blind, placebo-controlled, parallel study","volume":"10","author":"Higashikawa","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/jdv.13558","article-title":"Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers","volume":"30","author":"Tarstedt","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"adv00358","DOI":"10.2340\/00015555-3690","article-title":"Systematic literature review and network meta-analysis of the efficacy and acceptability of interventions in Actinic Keratoses","volume":"101","author":"Ezzedine","year":"2021","journal-title":"Acta Derm.-Venereol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2133.2007.07946.x","article-title":"Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis","volume":"157","author":"Moloney","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.pdpdt.2019.07.009","article-title":"Efficacy and safety of photodynamic therapy with amino-5-laevulinate nanoemulsion versus methyl-5-aminolaevulinate for actinic keratosis: A meta-analysis","volume":"27","author":"Fu","year":"2019","journal-title":"Photodiagnosis. Photodyn. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamadermatol.2014.1253","article-title":"Efficacy of photodynamic therapy vs other interventions in randomized clinical trials for the treatment of actinic keratoses: A systematic review and meta-analysis","volume":"150","author":"Patel","year":"2014","journal-title":"JAMA Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5021\/ad.2014.26.3.321","article-title":"Comparative study of photodynamic therapy with topical methyl aminolevulinate versus 5-aminolevulinic acid for facial actinic keratosis with long-term follow-up","volume":"26","author":"Ko","year":"2014","journal-title":"Ann. Dermatol."},{"key":"ref_24","first-page":"e37","article-title":"DL-PDT for AK: Multicentre trial comparing BF-200 ALA with MAL","volume":"181","author":"Ylitalo","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1089\/pho.2013.3670","article-title":"Optimization of photodynamic therapy using negative pressure","volume":"32","author":"Menezes","year":"2014","journal-title":"Photomed. Laser. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fphy.2015.00030","article-title":"Fluorescence guided PDT for optimization of the outcome of skin cancer treatment","volume":"3","author":"Blanco","year":"2015","journal-title":"Front. Phys."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"101681","DOI":"10.1016\/j.pdpdt.2020.101681","article-title":"Skin surface protoporphyrin IX fluorescence is associated with epidermal but not dermal fluorescence intensities","volume":"30","author":"Foged","year":"2020","journal-title":"Photodiagnosis. Photodyn. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.addr.2007.07.004","article-title":"Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models","volume":"59","author":"Godin","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jphotobiol.2009.07.001","article-title":"Porphyrin synthesis from aminolevulinic acid esters in endothelial cells and its role in photodynamic therapy","volume":"96","author":"Rodriguez","year":"2009","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Takahashi, O., Kirikoshi, R., and Manabe, N. (2017). Racemization of serine residues catalyzed by dihydrogen phosphate ion: A computational study. Catalysts, 7.","DOI":"10.3390\/catal7120363"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Dyakin, V.V., Wisniewski, T.M., and Lajtha, A. (2021). Racemization in post-translational modifications relevance to protein aging, aggregation and neurodegeneration: Tip of the iceberg. Symmetry, 13.","DOI":"10.3390\/sym13030455"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Borgia, F., Giuffrida, R., Caradonna, E., Vaccaro, M., Guarneri, F., and Cannav\u00f2, S.P. (2018). Early and late onset side effects of photodynamic therapy. Biomedicines, 6.","DOI":"10.3390\/biomedicines6010012"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaad.2009.03.048","article-title":"Pain associated with aminolevulinic acid-photodynamic therapy of skin disease","volume":"61","author":"Warren","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/bjd.17014","article-title":"A randomized intraindividual comparative study of methyl-5-aminolaevulinate vs. 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) in photodynamic therapy for actinic keratosis of the face and scalp","volume":"179","author":"Nagore","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/bjd.17311","article-title":"5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: A nonsponsored randomized double-blind multicentre trial","volume":"181","author":"Ylitalo","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/bjd.17867","article-title":"A randomized, double-blind trial comparing 5-aminolaevulinic acid nanoemulsion with methyl 5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis","volume":"181","author":"Szeimies","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_37","first-page":"925","article-title":"Current methods for photodynamic therapy in the US: Comparison of MAL\/PDT and ALA\/PDT","volume":"12","author":"Lee","year":"2013","journal-title":"J. Drugs Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2133.2011.10613.x","article-title":"AK-CT002 Study Group. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: Results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo","volume":"166","author":"Dirschka","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/jdv.15185","article-title":"A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis","volume":"33","author":"Dirschka","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0190-9622(91)70113-G","article-title":"A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck","volume":"24","author":"Olsen","year":"1991","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0781.2012.00684.x","article-title":"Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?","volume":"28","author":"Ibbotson","year":"2012","journal-title":"Photodermatol. Photoimmunol. Photomed."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/2\/346\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:12:28Z","timestamp":1760134348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/2\/346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["pharmaceutics14020346"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14020346","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}